These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24384938)

  • 21. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.
    King D; Jarjoura D; McEwen HA; Askew MJ
    J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta.
    Bargman R; Huang A; Boskey AL; Raggio C; Pleshko N
    Connect Tissue Res; 2010 Apr; 51(2):123-31. PubMed ID: 20053133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells.
    Xin X; Jiang X; Wang L; Stover ML; Zhan S; Huang J; Goldberg AJ; Liu Y; Kuhn L; Reichenberger EJ; Rowe DW; Lichtler AC
    Stem Cells Transl Med; 2014 Oct; 3(10):1125-37. PubMed ID: 25122686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipose-derived stem cells alleviate osteoporosis by enhancing osteogenesis and inhibiting adipogenesis in a rabbit model.
    Ye X; Zhang P; Xue S; Xu Y; Tan J; Liu G
    Cytotherapy; 2014 Dec; 16(12):1643-55. PubMed ID: 25231892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone Marrow Transplantation for Treatment of the Col1a2
    Lee LR; Peacock L; Ginn SL; Cantrill LC; Cheng TL; Little DG; Munns CF; Schindeler A
    Calcif Tissue Int; 2019 Apr; 104(4):426-436. PubMed ID: 30535573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo.
    Niyibizi C; Smith P; Mi Z; Phillips CL; Robbins P
    J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):84-91. PubMed ID: 11500956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
    Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW
    Endocrinology; 2002 May; 143(5):1594-601. PubMed ID: 11956140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts.
    Millard SM; Pettit AR; Ellis R; Chan JKY; Raggatt LJ; Khosrotehrani K; Fisk NM
    Stem Cell Reports; 2015 Nov; 5(5):682-689. PubMed ID: 26527386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatiotemporal Analyses of Osteogenesis and Angiogenesis via Intravital Imaging in Cranial Bone Defect Repair.
    Huang C; Ness VP; Yang X; Chen H; Luo J; Brown EB; Zhang X
    J Bone Miner Res; 2015 Jul; 30(7):1217-30. PubMed ID: 25640220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.
    Gioia R; Panaroni C; Besio R; Palladini G; Merlini G; Giansanti V; Scovassi IA; Villani S; Villa I; Villa A; Vezzoni P; Tenni R; Rossi A; Marini JC; Forlino A
    Stem Cells; 2012 Jul; 30(7):1465-76. PubMed ID: 22511244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model.
    Wang X; Wang C; Gou W; Xu X; Wang Y; Wang A; Xu W; Guo Q; Liu S; Lu Q; Meng H; Yuan M; Peng J; Lu S
    Stem Cell Res Ther; 2018 Oct; 9(1):272. PubMed ID: 30359311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
    Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
    Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
    Jones GN; Moschidou D; Abdulrazzak H; Kalirai BS; Vanleene M; Osatis S; Shefelbine SJ; Horwood NJ; Marenzana M; De Coppi P; Bassett JH; Williams GR; Fisk NM; Guillot PV
    Stem Cells Dev; 2014 Feb; 23(3):262-76. PubMed ID: 24028330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.
    Horwitz EM; Prockop DJ; Fitzpatrick LA; Koo WW; Gordon PL; Neel M; Sussman M; Orchard P; Marx JC; Pyeritz RE; Brenner MK
    Nat Med; 1999 Mar; 5(3):309-13. PubMed ID: 10086387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
    Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
    Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.
    Boban I; Jacquin C; Prior K; Barisic-Dujmovic T; Maye P; Clark SH; Aguila HL
    Bone; 2006 Dec; 39(6):1302-12. PubMed ID: 16938497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone.
    Vanleene M; Shefelbine SJ
    Bone; 2013 Apr; 53(2):507-14. PubMed ID: 23352925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bone marrow stromal cells in combination with biomaterials in early phases of distraction osteogenesis: An experimental study in a rabbit femur model.
    Montes-Medina L; Hernández-Fernández A; Gutiérrez-Rivera A; Ripalda-Cemboráin P; Bitarte N; Pérez-López V; Granero-Moltó F; Prosper F; Izeta A
    Injury; 2018 Nov; 49(11):1979-1986. PubMed ID: 30219381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of transgenic models in the evaluation of osteogenic differentiation of embryonic stem cells.
    Repic D; Torreggiani E; Franceschetti T; Matthews BG; Ivcevic S; Lichtler AC; Grcevic D; Kalajzic I
    Connect Tissue Res; 2013; 54(4-5):296-304. PubMed ID: 23782451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagen (I) homotrimer potentiates the osteogenesis imperfecta (oim) mutant allele and reduces survival in male mice.
    Lee KJ; Rambault L; Bou-Gharios G; Clegg PD; Akhtar R; Czanner G; van 't Hof R; Canty-Laird EG
    Dis Model Mech; 2022 Sep; 15(9):. PubMed ID: 36106514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.